SCOPUS 정보 검색 플랫폼

Volumn 11, Issue 18, 2000, Pages 2465-2472

Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy

(11) Delman, K A a Bennett, J J a Zager, J S a Burt, B M a McAuliffe, P F a Petrowsky, H a Kooby, D A a Hawkins, W G a Horsburgh, B C b Johnson, P b Fong, Y a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

b Neurovir (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

G 207; GENE PRODUCT; NV 1020; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; GENE THERAPY; HERPES SIMPLEX VIRUS 1; IMMUNITY; IMMUNOCOMPETENCE; LIVER CARCINOMA; LIVER METASTASIS; NONHUMAN; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE THERAPY; HERPES SIMPLEX; HUMANS; IMMUNITY; LIVER; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0034634863 PISSN: 10430342 EISSN: None Source Type: Journal
DOI: 10.1089/10430340050207957 Document Type: Article

Times cited : (88)

References (27)

1
- 0033135055
- Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors
- (1999) Cancer Res. , vol.59 , pp. 2055-2058
- Advani, S.J.¹ Chung, S.-M.² Yan, S.Y.³ Gillespie, G.Y.⁴ Markert, J.M.⁵ Whitley, R.J.⁶ Roizman, B.⁷ Weichselbaum, R.R.⁸

2
- 0034082389
- Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer
- (2000) J. Mol. Med. , vol.78 , pp. 166-174
- Bennett, J.J.¹ Kooby, D.A.² Delman, K.³ McAuliffe, P.⁴ Halterman, M.W.⁵ Federoff, H.⁶ Fong, Y.⁷

3
- 0031911004
- Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide
- (1998) Gene Ther. , vol.5 , pp. 189-195
- Bouvet, M.¹ Fang, B.² Ekmekcioglu, S.³ Ji, L.⁴ Bucana, C.D.⁵ Hamada, K.⁶ Grimm, E.A.⁷ Roth, J.A.⁸

4
- 0023387940
- Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection
- (1987) Proc. Natl. Acad. Sci. U.S.A. , vol.84 , pp. 5908-5912
- Cantin, E.M.¹ Eberle, R.² Baldick, J.L.³ Moss, B.⁴ Willey, D.E.⁵ Notkins, A.L.⁶ Openshaw, H.⁷

5
- 0033166680
- Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1
- (1999) Hum. Gene Ther. , vol.10 , pp. 1599-1606
- Carew, J.F.¹ Kooby, D.A.² Halterman, M.W.³ Federoff, H.J.⁴ Fong, Y.⁵

6
- 0032844251
- Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice
- (1999) Gene Ther. , vol.6 , pp. 1751-1758
- Chahlavi, A.¹ Rabkin, S.D.² Todo, T.³ Sundaresan, P.⁴ Martuza, R.L.⁵

7
- 0022646583
- Infections with herpes simplex viruses (first of two parts)
- (1999) N. Engl. J. Med. , vol.314 , pp. 686-691
- Corey, L.¹ Spear, P.G.²

8
- 0029770508
- Master of deception: A review of herpesvirus immune evasion strategies
- (1996) Immunol. Cell Biol. , vol.74 , pp. 513-522
- Davis-Poynter, N.J.¹ Farrell, H.E.²

9
- 18144437002
- Heteroclitic immunization induces tumor immunity
- (1999) J. Exp. Med. , vol.188 , pp. 1153-1561
- Dyall, R.¹ Bowne, W.B.² Weber, L.W.L.J.³ Szabo, P.⁴ Moroi, Y.⁵ Piskun, G.⁶ Lewis, J.J.⁷ Houghton, A.N.⁸ Nikolic-Zugic, J.⁹

10
- 0021276721
- Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity
- (1984) J. Virol. , vol.50 , pp. 805-812
- Glorioso, J.¹ Schroder, C.H.² Kumel, G.³ Szczesiul, M.⁴ Levine, M.⁵

11
- 7344262312
- Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector
- (1998) Gene Ther. , vol.5 , pp. 809-819
- Herrlinger, U.¹ Kramm, C.M.² Aboody-Guterman, K.S.³ Silver, J.S.⁴ Ikeda, K.⁵ Johnston, K.M.⁶ Pechan, P.A.⁷ Barth, R.F.⁸ Finkelstein, D.⁹ Chiocca, E.A.¹⁰ Louis, D.N.¹¹ Breakefield, X.O.¹²

12
- 0022446142
- Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C
- (1986) J. Virol. , vol.58 , pp. 36-42
- Johnson, D.C.¹ McDermott, M.R.² Chrisp, C.³ Glorioso, J.C.⁴

13
- 0032774578
- Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes Simplex vires type-1 (G207)
- (1999) FASEB J. , vol.13 , pp. 1325-1334
- Kooby, D.¹ Carew, J.² Halterman, M.³ Mack, J.⁴ Bertino, J.⁵ Blumgart, L.H.⁶ Federoff, H.⁷ Fong, Y.⁸

14
- 0031052384
- Use of a 'replication-restricted' herpes virus to treat experimental human malignant mesothelioma
- (1997) Cancer Res. , vol.57 , pp. 466-471
- Kucharczuk, J.C.¹ Randazzo, B.² Chang, M.Y.³ Amin, K.M.⁴ Elshami, A.A.⁵ Sterman, D.H.⁶ Rizk, N.P.⁷ Molnar-Kimber, K.L.⁸ Brown, S.M.⁹ Maclean, A.R.¹⁰ Litzky, L.A.¹¹ Fraser, N.W.¹² Albelda, S.M.¹³ Kaiser, L.R.¹⁴

15
- 0022574086
- A novel approach to the generation and identification of experimental hepatic metastases in a murine model
- (1986) J. Natl. Cancer Inst. , vol.76 , pp. 309-322
- Lafreniere, R.¹ Rosenberg, S.A.²

16
- 0023278484
- The mechanisms of antiviral immunity induced by a vaccinia vires recombinant expressing herpes simplex virus type 1 glycoprotein D: Clearance of local infection
- (1987) J. Immunol. , vol.138 , pp. 3431-3437
- Martin, S.¹ Rouse, B.T.²

17
- 0023777661
- In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: Construction and evaluation in rodents
- (1988) J. Infect. Dis. , vol.158 , pp. 602-614
- Meigner, B.¹ Longnecker, R.² Roizman, B.³

18
- 0025280142
- In vivo behavior of genetically engineered herpes simplex Viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus)
- (1990) J. Infect. Dis. , vol.162 , pp. 313-320
- Meigner, B.¹ Martin, B.² Whitley, R.J.³ Roizman, B.⁴

19
- 0029023868
- Attenuated multi-mutated herpes simplex vires-1 for the treatment of malignant gliomas
- (1995) Nat. Med. , vol.1 , pp. 938-943
- Mineta, T.¹ Rabkin, S.D.² Yazaki, T.³ Hunter, W.D.⁴ Martuza, R.L.⁵

20
- 0028047306
- Immunization with replication-defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection
- (1994) J. Virol. , vol.68 , pp. 689-696
- Morrison, L.A.¹ Knipe, D.M.²

21
- 0026447939
- Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection
- (1992) J. Virol. , vol.66 , pp. 7067-7072
- Nguyen, L.H.¹ Knipe, D.M.² Finberg, R.W.³

22
- 0021997488
- Role of antibody in primary and recurrent herpes simplex vires infection
- (1985) J. Virol. , vol.53 , pp. 944-948
- Simmons, A.¹ Nash, A.A.²

23
- 0032505773
- Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1
- (1998) Hum. Gene Ther. , vol.9 , pp. 2177-2185
- Toda, M.¹ Rabkin, S.D.² Martuza, R.L.³

24
- 0033199929
- Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207
- (1999) Hum. Gene Ther. , vol.10 , pp. 2237-2243
- Walker, J.R.¹ McGeagh, K.G.² Sundaresan, P.³ Jorgensen, T.J.⁴ Rabkin, S.D.⁵ Martuza, R.L.⁶

25
- 0028328261
- Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy
- (1994) Proc. Natl. Acad. Sci. , vol.91 , pp. 4407-4411
- Yang, Y.¹ Nunes, F.A.² Berencsi, K.³ Furth, E.E.⁴ Gonczol, E.⁵ Wilson, J.M.⁶

26
- 0028937785
- Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
- (1995) J. Virol. , vol.69 , pp. 2004-2015
- Yang, Y.¹ Li, Q.² Ertl, H.C.J.³ Wilson, J.M.⁴

27
- 0032471162
- Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector
- (1998) Ann. Surg. , vol.228 , pp. 366-374
- Yoon, S.¹ Carroll, N.M.² Chiocca, E.A.³ Tanabe, K.K.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.